Healthcare -
Biotechnology - NYSE - DK
$ 78.69
-5.27 %
$ 349 B
Market Cap
26.86
P/E
NVO - OPERATING INCOME
Operating Income NVO - Novo Nordisk A/S
103 B
LAST VALUE
32.25%
2 YEAR CAGR
16.77%
5 YEAR CAGR
12.53%
10 YEAR CAGR